DEXCOM INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-18. The offering totals $7.2M, of which $7.2M was reported sold. Industry: Biotechnology.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| Steven R Altman | Director | San Diego, CA |
| Nicholas H Augustinos | Director | San Diego, CA |
| Mark S Foletta | Director | San Diego, CA |
| Terrance H Gregg | Director | San Diego, CA |
| Barbara E Kahn | Director | San Diego, CA |
| Jonathan T Lord | Director | Irvine, CA |
| Kevin Sayer | Director | San Diego, CA |
| Jay S Skyler | Director | New York, NY |
| Eric T Topol | Director | San Diego, CA |
| Andrew K Balo | Executive Officer | San Diego, CA |
| Richard K Doubleday | Executive Officer | San Diego, CA |
| Terrance H Gregg | Executive Officer | San Diego, CA |
| John D Lister | Executive Officer | San Diego, CA |
| Jeffrey D Moy | Executive Officer | San Diego, CA |
| Steven R Pacelli | Executive Officer | San Diego, CA |
| Jess R Roper | Executive Officer | San Diego, CA |
| Kevin Sayer | Executive Officer | San Diego, CA |
| Jorge R Valdes | Executive Officer | San Diego, CA |
| John K Lister | Executive Officer | San Diego, CA |
| Kevin H Sayer | Director | San Diego, CA |
| Kevin H Sayer | Executive Officer | San Diego, CA |
| Eric S Topol | Director | San Diego, CA |
| Jeffrey K Moy | Executive Officer | San Diego, CA |
| Nicholas R Augustinos | Director | San Diego, CA |
| Jess S Roper | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2012-04-12 | D | $7.6M | $4.0M |
| 2012-04-12 | D/A | $7.6M | $4.0M |